Prior capital management was the biggest disappointment I had, but it looks to be turning a corner.
if they needed to raise cash surely they would have at the same time as announcing the FDA approval and US patent.
it’d be a shame to do so now after the market response.
I reckon they’ve got some time on their hands with the R&D rebate due imminently.
Link To Webinar, 31 October 2022, page-13
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.75M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NUH (ASX) Chart |
Day chart unavailable